LOVELACE BIOMEDICAL RESEARCH INSTITUTE
Federal contract awards won by LOVELACE BIOMEDICAL RESEARCH INSTITUTE (UEI MBT9RXJJ7428), 2017–2026 — public record from USAspending.
Showing awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
39
awards
$10,952,501,710
total value
2
agencies
Agencies buying from LOVELACE BIOMEDICAL RESEARCH INSTITUTE
What LOVELACE BIOMEDICAL RESEARCH INSTITUTE sells
541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) (15)541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) (12)541690 — OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES (4)541712 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) (3)541380 — TESTING LABORATORIES (2)541720 — RESEARCH AND DEVELOPMENT IN THE SOCIAL SCIENCES AND HUMANITIES (1)541380 — TESTING LABORATORIES AND SERVICES (1)511210 — SOFTWARE PUBLISHERS (1)
Awards
RTOR BIO-AMT-2312: ASSESSMENT OF THE THERAPEUTIC POTENTIAL OF CHLOROQUINE AND OSELTAMIVIR IN TWO (2) LETHAL MODELS OF INFLUENZA A H5N1
Department of Health and Human Services · $3,723,027 · Aug 26, 2026
EVALUATION AND TESTING SERVICES (ETS) FOR VACCINES AND OTHER BIOLOGICS FOR INFECTIOUS DISEASES.
Department of Health and Human Services · $136,588,701 · Sep 30, 2025
SOLE SOURCE AWARD OF A 24-MONTH PERIOD, FIRM FIXED PRICE (FFP), ENDS TOXICOLOGICAL STUDIES FOR CENTER FOR TOBACCO PRODUCTS (CTP).
Department of Health and Human Services · $7,058,882 · Sep 19, 2025
PHARMACOLOGY STUDIES AND ANIMAL MODEL DEVELOPMENT AND RELATED SERVICES FOR DRUG DEVELOPMENT
Department of Health and Human Services · $48,882,666 · Aug 6, 2024
SAFETY EVALUATION AND TOXICOLOGY STUDIES AND RELATED SERVICES FOR DRUG DEVELOPMENT
Department of Health and Human Services · $48,622,546 · Jun 20, 2024
EFFICACY AND SAFETY EVALUATION OF LEAD GENE THERAPY CANDIDATE IN NEUROMUSCULAR JUNCTION (NMJ) DISEASE MOUSE MODELS AND BIOANALYTICAL ASSAY METHODS DEVELOPMENT
Department of Health and Human Services · $1,595,870 · Sep 29, 2023
TASK ORDER 2 - EXAMINING THE INFLUENCE OF SYNTHETIC COOLING AGENTS ON CIGARETTE SENSORY AND SUBJECTIVE EFFECTS AND USE BEHAVIOR
Department of Health and Human Services · $1,251,731 · Sep 29, 2023
RADNUC 2201: PERFORMANCE VERIFICATION OF INSTITUTIONAL RADIATION DOSE RESPONSE FOR ACUTE RADIATION SYNDROME (ARS) ANIMAL MODELS (RODENT, RABBIT, MINIPIG, OR NON-HUMAN PRIMATE [NHP])
Department of Health and Human Services · $1,986,391 · Sep 29, 2023
TASK ORDER 1 -TITLE: ARE REDUCTIONS IN BOE, BOPH, AND OTHER HEALTH RISK MARKERS PROPORTIONAL TO REDUCTIONS IN CIGARETTE SMOKING UPON SWITCHING TO ENDS
Department of Health and Human Services · $3,872,713 · Sep 27, 2023
AWARD OF FIVE-YEAR IDIQ FOR CTP- ASSESSING TOBACCO-RELATED CLINICAL OUTCOMES AND HUMAN BEHAVIORS IN TOBACCO
Department of Health and Human Services · $25,000,000 · Sep 26, 2023
RESOURCES TO ADVANCE PEDIATRICS AND HIV PREVENTION SCIENCE
Department of Health and Human Services · $98,878,757 · Apr 15, 2023
LOVELACE BIOMEDICAL RESEARCH INSTITUTE - BASE (BIO) - IDIQ FOR BARDA BIOLOGICAL ANIMAL MODEL AND MCM DEVELOPMENT
Department of Health and Human Services · $100,000,000 · Sep 30, 2022
ASSESSMENT OF POTENTIAL TREATMENTS FOR DRUG-INDUCED RESPIRATORY DEPRESSION AND OVERDOSE TOXICITY. ORDERING PERIOD: SEPTEMBER 26, 2022 - SEPTEMBER 25, 2027. N01DA-22-8958.
Department of Health and Human Services · $6,500,000 · Sep 26, 2022
GLP REPEAT DOSE TOXICOLOGY STUDY FOR BPL-24910
Department of Health and Human Services · $716,374 · Sep 26, 2022
CTP-2022-111127 - SALTS
Department of Health and Human Services · $2,076,573 · Sep 22, 2022
LOVELACE BIOMEDICAL RESEARCH INSTITUTE (RADNUC) - IDIQ FOR BARDA CRN ANIMAL MODEL DEVELOPMENT
Department of Health and Human Services · $100,000,000 · Sep 9, 2022
GENE THERAPY RESOURCE PROGRAM (GTRP): PHARMACOLOGY AND TOXICOLOGY CORE LABORATORY
Department of Health and Human Services · $1,143,792 · Sep 9, 2022
LOVELACE BIOMEDICAL RESEARCH INSTITUTE(CHEM) - IDIQ FOR BARDA CRN ANIMAL MODEL DEVELOPMENT
Department of Health and Human Services · $45,000,000 · Jul 28, 2022
OMNIBUS IV MILITARY MEDICAL RESEARCH AND DEVELOPMENT
Department of Defense · $10,000,000,000 · Jun 20, 2022
BIOANALYTICAL SUPPORTS FOR A GLP TOX/BIODISTRIBUTION STUDY IN MINI-PIGS
Department of Health and Human Services · $747,851 · Jun 17, 2022
THE CONTRACTOR SHALL PERFORM THE TRANSFER, VALIDATION AND QUALIFICATION OF BIOANALYTICAL METHODS FOR DETECTION OF CABOTEGRAVIR AND LEVONORGESTREL IN RAT AND NONHUMAN PRIMATE PLASMA
Department of Health and Human Services · $486,301 · Nov 15, 2021
EO14042 - THE CONTRACTOR SHALL PROVIDE PRECLINICAL DEVELOPMENT SUPPORT FOR CANDIDATE PRODUCTS AND DRUG DEVELOPMENT ACTIVITIES.
Department of Health and Human Services · $107,274,471 · Nov 15, 2021
EO14042 - THE CONTRACTOR SHALL PROVIDE NIAID WITH PRECLINICAL PRODUCT DEVELOPMENT SERVICES FOR CANDIDATE PRODUCTS.
Department of Health and Human Services · $150,000,000 · Nov 1, 2021
EFFICACY AND SAFETY EVALUATION OF A LEAD GENE THERAPY CANDIDATE IN METHYL MELANOMIC ACIDEMIA (MMAB) DISEASE MOUSE MODELS AND BIOANALYTICAL ASSAY METHODS DEVELOPMENT.
Department of Health and Human Services · $623,883 · Sep 29, 2021
CHARACTERIZATION OF A NON-PARALYZING BONT-BASED BIOPHARMACEUTICAL FOR THE TREATMENT OF NEUROPATHIC PAIN
Department of Health and Human Services · $1,155,097 · Sep 24, 2021
Researching this competitor? BidCatch doesn't just show you what they won — it sends you the open bids in your trade every morning, before they're awarded. Free for 14 days, then $49.99/month.
Search open bids